Hikma Expands its Global Injectables Business - Live Webcast

LONDON, October 29, 2010 - Hikma Pharmaceuticals, the multinational pharmaceutical group, announces
that it has signed an agreement to acquire Baxter Healthcare Corporation's US
generic injectables business for a cash consideration of $112 million.

There will be a live analyst and investor webcast outlining the event on
www.cantos.com at 0930 BST. An on-demand replay of the webcast will
also be available.

Cantos.com, the online financial broadcaster, features in-depth
interviews, documentaries and webcasts with senior company executives. If you
would like to contact us, please email amanda.alexander@cantos.com or phone
+44-207-936-1352.

If you would like to contact us, please email amanda.alexander at cantos.com or phone +44-207-936-1352.